Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies

In this retrospective study, we investigated adverse events and outcomes in patients treated with bevacizumab for ovarian, fallopian tube, or primary peritoneal cancers at a single hospital. We determined the cumulative incidences of various bevacizumab-related adverse events and the correlation bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Shu-Ping, Hsu, Heng-Cheng, Tai, Yi-Jou, Chen, Yu-Li, Chiang, Ying-Cheng, Chen, Chi-An, Cheng, Wen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498445/
https://www.ncbi.nlm.nih.gov/pubmed/31105567
http://dx.doi.org/10.3389/fphar.2019.00426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498445/
https://www.ncbi.nlm.nih.gov/pubmed/31105567
http://dx.doi.org/10.3389/fphar.2019.00426

Ejemplares similares